| 常用名 | 5-(2-氨基-1-(4-吗啉苯基)-1H-苯并咪唑-6-基)-N-(2-氟 苯基)-2-甲氧基吡啶-3-磺酰胺 | CAS号 | 1416334-69-4 |
|---|---|---|---|
| 价格 | 纯度 | 98.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: GSK-A1 is a selective type III phosphatidylinositol 4-kinase PI4KA (PI4KIIIα) inhibitor with a pIC50 of 8.5-9.8. GSK-A1 inhibits PtdIns(4,5)P2 resynthesis with an IC50 of about 3 nM. GSK-A1 potently decreases the levels of PtdIns(4)P with a negligible effect on PtdIns(4,5)P2. GSK-A1 has the potential for anti-hepatitis C virus (HCV) research[1]. 物理化学性质: CAS号:1416334-69-4 常用中文名:5-(2-氨基-1-(4-吗啉苯基)-1H-苯并咪唑-6-基)-N-(2-氟 苯基)-2-甲氧基吡啶-3-磺酰胺 常用英文名:PI4KA inhibitor-A1 分子式:C29H27FN6O4S 分子量:574.626 密度:1.5±0.1 g/cm3 沸点:829.8±75.0 °C at 760 mmHg 熔点:N/A 闪点:455.7±37.1 °C 储存条件:-20°C |